Table 4.
Models | Discrimination C-Indexa | Goodness-of-Fit, Likelihood Ratio X2 (p value)b | Calibration Cox X2c | NRId (p value) | IDIe (p value) | Percent reclassifiedf |
---|---|---|---|---|---|---|
Non-lipid covariates and total/HDL cholesterol ratio (referent model) | 0.784 | Referent | 16.7 | Referent | Referent | Referent |
Referent model covariates plus LDLNMR | 0.785 | 2.01 (0.16) |
17.2 | 0% (0.52) |
0.0% (0.65) |
1.1 |
Referent model covariates plus apolipoprotein B100 | 0.786 | 10.5 (0.001) |
14.3 | 1.9% (0.02) |
0.1% (0.12) |
2.6 |
All statistical measures were calculated at 10-years of follow-up.
The c-index for the referent model (non-lipid covariates and total/HDL cholesterol ratio) was not statistically significantly different from the models that additionally included LDLNMR or apolipoprotein B100.
Values are likelihood ratio X2 and p values obtained from the Cox proportional hazards regression comparing models that added either LDLNMR or apolipoprotein B100 to the referent model (non-lipid covariates and total/HDL cholesterol ratio). A higher X2 value indicates a better model fit.
Values are modified Hosmer-Lemeshow X2, comparing differences between the predicted and actual event rates (X2 values greater than 20 indicate poor calibration).19
NRI is the net reclassification index, which compares the proportions moving up or down in clinical categories in cases versus controls, comparing models that added either LDLNMR or apolipoprotein B100 to the referent model.
IDI is the integrated discrimination improvement, comparing the integrals of sensitivity and specificity under two models (referent model compared with the model that added either LDLNMR or apolipoprotein B100).
The proportion of individuals that move up or down a risk category using the model that incorporates either LDLNMR or apolipoprotein B100 compared with the referent model.